Filter
1726
Filtered Results: 1726
Text search:
drug
registration
Featured
Recommendations
136
New Publications
557
Language
Document type
No document type
1125
Studies & Reports
224
Guidelines
188
Manuals
73
Strategic & Response Plan
68
Fact sheets
17
Training Material
16
Situation Updates
9
Resource Platforms
5
Brochures
1
Countries / Regions
India
168
Kenya
63
Uganda
48
Ethiopia
46
South Africa
42
Tanzania
41
Global
41
Bangladesh
39
Sierra Leone
38
Nigeria
38
Ghana
37
Nepal
37
Malawi
34
Western and Central Europe
34
Liberia
31
Myanmar / Burma
31
Namibia
27
Rwanda
25
Africa
25
Ukraine
24
Zambia
21
Latin America and the Carribbean
19
Eastern Europe
19
Zimbabwe
17
Cambodia
17
Botswana
17
Philippines
15
South–East Asia Region
15
Lesotho
14
Asia
13
Indonesia
11
Syria
9
Congo, Democratic Republic of
8
Mozambique
7
Eswatini/ Swaziland
7
West and Central Africa
6
Russia
6
Pakistan
5
Brazil
5
Colombia
5
East and Southern Africa
5
Senegal
4
South Sudan
4
Benin
4
Sri Lanka
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Albania
4
Tajikistan
4
Georgia
4
Cameroon
3
Haiti
3
Iraq
3
Sudan
3
Argentina
3
Western Pacific Region
3
Bhutan
3
Venezuela
3
Timor Leste/ East Timor
3
Moldova
3
Burkina Faso
2
Jordan
2
Afghanistan
2
Germany
2
Thailand
2
Papua New Guinea
2
North Macedonia
2
Bolivia
2
Libya
2
Angola
2
Chile
2
Paraguay
2
Armenia
2
Laos
2
Iran
2
Uruguay
2
United Kingdom
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Lebanon
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Central African Republic
1
Peru
1
Greece
1
Madagascar
1
Fiji
1
North Korea
1
Italy
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Vietnam
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
877
Clinical Guidelines
133
Public Health
84
Women & Child Health
45
Pharmacy & Technologies
34
Key Resources
28
Capacity Building
20
Toolboxes
TB
193
HIV
167
Mental Health
80
AMR
79
Pharmacy
76
COVID-19
52
NTDs
42
NCDs
34
Caregiver
33
Conflict
27
Refugee
23
Rapid Response
20
Disability
16
Global Health Education
16
Ebola
13
Planetary Health
8
Natural Hazards
7
Specific Hazards
7
Polio
5
Health Financing Toolbox
5
Zika
4
Cholera
3
Social Ethics
2
Health Financing
1
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The micronutrient powders will be distributed at the health facilities where instructions on use will be provided by Health Care Providers. Community Health Volunteers will educate, counsel, and mobilize caregivers at the community level to visit health facilities for nutrition assessment and provis...
Types of radiotherapy equipment covered by the guide include external beam radiotherapy machines (both Cobalt-60 and linear accelerators), brachytherapy devices that apply radiation sources directly to tumours and complementary imaging devices such as conventional or computed tomography (CT) simulat...
Primary health care offers a cost–effective route to achieving universal health coverage (UHC). However, primary health-care systems are weak in many low- and middle-income countries and often fail to provide comprehensive, people-centred, integrated care. We analysed the primar...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Palliative Care Toolkits and Training Manual
recommended
This toolkit has been written to empower health workers in resource-poor settings to integrate palliative care into the work they are doing by grafting the missing elements of care onto what is already in place. The WHPCA, Hospice UK and Palliative Care Works have led this updating of the Palliative...
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
Consultancy Report May 2022
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
